07/30/2025
5:30 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
07/28/2025
11:15 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form EFFECT | |
07/28/2025
8:20 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2025
12:21 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-1/A | |
07/15/2025
2:05 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-1/A | |
07/15/2025
2:38 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/06/2025
11:15 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form EFFECT | |
06/27/2025
3:46 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-3/A | |
06/20/2025
3:30 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2025
9:53 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
10:04 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for HEB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Hemispherx BioPharma and its competitors with MarketBeat's FREE daily newsletter. |
06/12/2025
3:50 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
3:35 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
KELLNER TED D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2025
3:35 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2025
3:35 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
MITCHELL WILLIAM M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2025
2:42 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
4:19 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Rodino Peter W III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
9:30 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2025
3:45 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEF 14A | |
04/01/2025
4:15 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/27/2025
6:17 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/18/2025
4:11 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
MITCHELL WILLIAM M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:10 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
CHEMEROW DAVID I. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:10 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
BRYAN NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
8:36 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
9:00 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
1:14 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
BRYAN NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
12:14 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
3:45 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form PRE 14A | |
02/28/2025
7:00 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
7:45 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2025
7:50 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2025
7:35 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
8:24 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-1/A | |
02/07/2025
7:55 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
7:30 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
3:05 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
BRYAN NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
3:05 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
MITCHELL WILLIAM M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
8:09 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-1/A | |
01/23/2025
4:26 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/21/2025
3:32 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Why More Investors Are Using Family Trusts to Protect Their Wealth (Ad) For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026.
If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest. Click here to get your free advisor matches and start planning your legacy today. |
12/23/2024
3:30 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
2:23 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
KELLNER TED D (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/23/2024
10:11 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SCHEDULE 13D/A | |
12/20/2024
4:00 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:30 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
MITCHELL WILLIAM M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
12:38 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
3:41 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/16/2024
3:59 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/16/2024
3:59 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/13/2024
3:43 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/12/2024
3:49 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/12/2024
3:09 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/11/2024
7:52 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/10/2024
3:39 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/10/2024
8:01 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/10/2024
8:06 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
12/09/2024
4:25 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/06/2024
3:50 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/05/2024
3:37 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/03/2024
5:29 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
BRYAN NANCY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:33 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
APPELROUTH STEWART (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:36 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
MITCHELL WILLIAM M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:55 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
12/02/2024
3:05 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/27/2024
4:26 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/27/2024
3:15 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
3:05 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/26/2024
3:05 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/25/2024
4:16 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/22/2024
4:26 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/21/2024
11:02 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
APPELROUTH STEWART (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
11:04 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
11:46 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
3:59 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/14/2024
3:25 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DFAN14A | |
11/14/2024
2:21 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
11/06/2024
8:02 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form DEFC14A | |
11/04/2024
3:59 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form DEFA14A | |
11/04/2024
6:00 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
| Form DEFC14A | |
10/30/2024
3:50 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form PRER14A | |
10/30/2024
11:53 AM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form PRRN14A | |
10/18/2024
3:34 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
KELLNER TED D (Filed by)
| Form PREC14A | |
10/15/2024
3:33 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
| Form PREC14A | |
10/01/2024
2:55 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
12:12 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
09/30/2024
7:22 AM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 424B5 | |
09/17/2024
11:05 AM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
2:45 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
4:15 PM | Hemispherx BioPharma (Issuer)
AIM ImmunoTech Inc. (Issuer)
Equels Thomas K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:45 PM | Hemispherx BioPharma (Filer)
AIM ImmunoTech Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Why More Investors Are Using Family Trusts to Protect Their Wealth (Ad) For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026.
If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest. Click here to get your free advisor matches and start planning your legacy today. |
09/11/2024
4:40 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SC 13D/A | |
09/03/2024
8:43 PM | Hemispherx BioPharma (Subject)
AIM ImmunoTech Inc. (Subject)
Deutsch Todd (Filed by)
| Form SC 13D/A | |
MarketBeat All Access